Explore CACNA2D2 gene products and cross-species
research data at TarMart platform. Discover comprehensive
biological information, expression tools, and therapeutic
insights for Homo sapiens (human), Cynomolgus monkeys, rodents
(mouse/rat), canines, felines, bovines, and equines. Your
premier destination for multi-species gene research solutions
Target
sublocation: Transmembrane Protein.
Calcium channels mediate the entry of calcium ions into the cell upon membrane polarization. This gene encodes the alpha-2/delta subunit of the voltage-dependent calcium channel complex. The complex consists of the main channel-forming subunit alpha-1, and auxiliary subunits alpha-2/delta, beta, and gamma. The auxiliary subunits function in the assembly and membrane localization of the complex, and modulate calcium currents and channel activation/inactivation kinetics. The subunit encoded by this gene undergoes post-translational cleavage to yield the extracellular alpha2 peptide and a membrane-anchored delta polypeptide. This subunit is a receptor for the antiepileptic drug, gabapentin. Mutations in this gene are associated with early infantile epileptic encephalopathy. Single nucleotide polymorphisms in this gene are correlated with increased sensitivity to opioid drugs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Mar 2014]
| Target ID |
GM-T28132
|
| Target Name |
CACNA2D2
|
Gene Group ldentifer (Target Gene ID in Homo
species)
|
9254
|
| Gene ID |
100061645 (Equus caballus), 100688870 (Canis lupus familiaris), 101095887 (Felis catus), 300992 (Rattus norvegicus) 56808 (Mus musculus), 702429 (Macaca mulatta), 785909 (Bos taurus), 9254 (Homo sapiens)
|
| Target Alternative Names |
CACNA2D,CACNA2D2,CASVDD,Cacna2d,Cacna2d2,Voltage-dependent calcium channel subunit alpha-2/delta-2,Voltage-gated calcium channel subunit alpha-2/delta-2,a2d2,du,mKIAA0558,td,torpid
|
| Uniprot Accession |
Q8CFG6,Q6PHS9,Q9NY47
|
| Protein Sub-location |
Transmembrane Protein
|
| Category |
Therapeutics Target
|
| Disease from KEGG |
MAPK signaling pathway, Adrenergic signaling in cardiomyocytes, Oxytocin signaling pathway, Hypertrophic cardiomyopathy, Arrhythmogenic right ventricular cardiomyopathy, Dilated cardiomyopathy
|
| Gene Ensembl |
ENSECAG00000001156, ENSCAFG00845020679, ENSMUSG00000010066, ENSMMUG00000007022, ENSBTAG00000009489, ENSG00000007402
|
Pre-made viral vector of CACNA2D2 cDNA Clones/ORF Plasmid
CACNA2D2 siRNA/miRNA/oligo for RNA interfence (RNAi)
| Cat No. | Product Name | GeneID | Species | Grade | Detail |
|---|
| pGMoligo9254 | Pre-made Human CACNA2D2/CASVDD/CACNA2D siRNA oligo Duplex | 9254 | Human | In-vitro grade; in-vivo grade | Detail |
| pGMoligo300992 | Pre-made Rat Cacna2d2 siRNA oligo Duplex | 300992 | Rat | In-vitro grade; in-vivo grade | Detail |
| pGMoligo56808 | Pre-made Mouse Cacna2d2/du/td siRNA oligo Duplex | 56808 | Mouse | In-vitro grade; in-vivo grade | Detail |
| pGMoligo702429 | Pre-made Cynomolgus/Rhesus macaque CACNA2D2 siRNA oligo Duplex | 702429 | Cynomolgus/Rhesus macaque | In-vitro grade; in-vivo grade | Detail |
| pGMoligo101095887 | Pre-made Cat/Feline CACNA2D2 siRNA oligo Duplex | 101095887 | Cat/Feline | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100688870 | Pre-made Dog/Canine CACNA2D2 siRNA oligo Duplex | 100688870 | Dog/Canine | In-vitro grade; in-vivo grade | Detail |
| pGMoligo785909 | Pre-made Bovines/Cattle CACNA2D2 siRNA oligo Duplex | 785909 | Bovines/Cattle | In-vitro grade; in-vivo grade | Detail |
| pGMoligo100061645 | Pre-made Equine/Horse CACNA2D2 siRNA oligo Duplex | 100061645 | Equine/Horse | In-vitro grade; in-vivo grade | Detail |
CACNA2D2 antibody/GMab
| Cat No. | Species | Antibody Name | Format | Classified by tag | Detail |
|---|
| GM-Tg-hg-T28132-Ab | Human | Anti-Human CACNA2D2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-rg-T28132-Ab | Rat | Anti-Rat CACNA2D2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-mg-T28132-Ab | Mouse | Anti-Mouse CACNA2D2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cynog-T28132-Ab | Cynomolgus/Rhesus macaque | Anti-Cynomolgus/Rhesus macaque CACNA2D2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-felg-T28132-Ab | Cat/Feline | Anti-Cat/Feline CACNA2D2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-cang-T28132-Ab | Dog/Canine | Anti-Dog/Canine CACNA2D2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-bovg-T28132-Ab | Bovines/Cattle | Anti-Bovines/Cattle CACNA2D2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
| GM-Tg-equg-T28132-Ab | Equine/Horse | Anti-Equine/Horse CACNA2D2 monoclonal antibody | mab | FACS/Biofunctional Antibody, Therapeutics Target antibody | Detail |
CACNA2D2 VLP (virus-like particle)/protein
| Cat No. | Species | Antigen Name | Expression Platform | Detail |
|---|
| GM-Tg-hg-T28132-Ag | Human | Human CACNA2D2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-rg-T28132-Ag | Rat | Rat CACNA2D2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-mg-T28132-Ag | Mouse | Mouse CACNA2D2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cynog-T28132-Ag | Cynomolgus/Rhesus macaque | Cynomolgus/Rhesus macaque CACNA2D2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-felg-T28132-Ag | Cat/Feline | Cat/Feline CACNA2D2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-cang-T28132-Ag | Dog/Canine | Dog/Canine CACNA2D2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-bovg-T28132-Ag | Bovines/Cattle | Bovines/Cattle CACNA2D2 VLP (virus-like particle) | HEK293 | Products Developing |
| GM-Tg-equg-T28132-Ag | Equine/Horse | Equine/Horse CACNA2D2 VLP (virus-like particle) | HEK293 | Products Developing |